Article info
PDFClinical science
Long-term safety and tolerability of subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium in Asian Stargardt disease patients
- Correspondence to Won Kyung Song, Department of Ophthalmology, CHA Bundang Medical Center, 55. CHA University Seongnam, The Republic of Korea; songwkmd{at}daum.net
Citation
Long-term safety and tolerability of subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium in Asian Stargardt disease patients
Publication history
- Received March 4, 2020
- Revised June 18, 2020
- Accepted June 21, 2020
- First published July 29, 2020.
Online issue publication
May 20, 2021
Article Versions
- Previous version (29 July 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.